CANDI COEUILLE: Open Payments
NPI 1720849003 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $383 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $119 |
| BridgeBio Pharma, Inc. | 2 | $92 |
| PFIZER INC. | 2 | $55 |
| HEARTFLOW, INC. | 1 | $47 |
| Novo Nordisk Inc | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: UPTRAVI, Attruby, WAINUA, ELIQUIS, FFRct, FARXIGA, Wegovy, VERQUVO.
Industry payments across WA — which companies pay providers there.
